These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9113048)

  • 41. [Are ketolides replacing macrolides in chronic bronchitis?].
    Adam D
    Internist (Berl); 2002 Jul; 43(7):887-8. PubMed ID: 12219690
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antibiotic prophylaxis in patients at high risk of nosocomial outbreak of legionellosis].
    Longuet P; Duval X; Le Moing V; Scanvic-Hameg A; Leport C; Vildé JL
    Presse Med; 1999 Oct; 28(32):1755-6. PubMed ID: 10566278
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical efficacy of roxithromycin in respiratory tract infections.
    Ludwig E; Graber H; Bárándy Z; Lányi
    J Chemother; 1989 Jul; 1(4 Suppl):796-7. PubMed ID: 16312644
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibiotic treatment of lower respiratory tract infections.
    Cohen R; Angoulvant F; Biscardi S; Madhi F; Dubos F; Gillet Y
    Arch Pediatr; 2017 Dec; 24(12S):S17-S21. PubMed ID: 29290229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrolide antibiotics roxithromycin vs. azithromycin for preterm premature rupture of membranes: a retrospective comparison.
    Schreiber H; Shitrit P; Man-El G; Engel O; Berkovitz A; Biron-Shental T
    Arch Gynecol Obstet; 2019 Sep; 300(3):569-573. PubMed ID: 31227871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibiotic resistance: infections of the upper respiratory tract and bronchi. When are antibiotics necessary?].
    Zellweger C; Täuber MG
    Ther Umsch; 2002 Jan; 59(1):21-9. PubMed ID: 11851042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
    Yasuda Y; Kasahara K; Mizuno F; Nishi K; Mikasa K; Kita E
    Antimicrob Agents Chemother; 2007 May; 51(5):1741-52. PubMed ID: 17353244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
    Tilyard MW; Dovey SM
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Con: antibiotic use in exacerbations of chronic bronchitis.
    Nicotra MB; Kronenberg RS
    Semin Respir Infect; 1993 Dec; 8(4):254-8. PubMed ID: 7938922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Revaluation of current antimicrobials. Series 18: Roxithromycin].
    Niki Y; Tamaoki J
    Jpn J Antibiot; 1994 Oct; 47(10):1275-82. PubMed ID: 7807689
    [No Abstract]   [Full Text] [Related]  

  • 52. [Efficacy of roxithromycin in the treatment of lower respiratory tract infections in patients with chronic respiratory disease].
    Marcos Sánchez F; Celdrán Gil J; Llorente Domingo P; Durán Pérez-Navarro A
    An Med Interna; 1991 Jun; 8(6):312-3. PubMed ID: 1888851
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of roxithromycin with co-amoxiclav in patients with sinusitis.
    Chatzimanolis E; Marsan N; Lefatzis D; Pavlopoulos A
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():81-4. PubMed ID: 9579718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Roxithromycin (Rulid) in treatment of Chlamydia trachomatis genital infections in women].
    Radowicki S; Tyc M; Kulesza E; Dowgiałło-Smolarczyk J
    Ginekol Pol; 1995 Jun; 66(6):354-6. PubMed ID: 8522242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.
    Lorenz J; Thate-Waschke IM; Mast O; Kubin R; Rychlik R; Pfeil T; Daniel D; Tillotson GS
    J Int Med Res; 2001; 29(2):74-86. PubMed ID: 11393351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of bacterial broncho-pulmonary diseases].
    Ben Chaabane T
    Tunis Med; 1988; 66(8-9):585-6. PubMed ID: 3206554
    [No Abstract]   [Full Text] [Related]  

  • 57. Optimal antibiotic therapy in bronchopulmonary infections.
    Neu HC
    Infection; 1980; Suppl 1():62-9. PubMed ID: 7399717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endobronchial infection in cystic fibrosis.
    Smith AL; Ramsey B; Redding G; Haas J
    Acta Paediatr Scand Suppl; 1989; 363():31-6. PubMed ID: 2701922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Some aspects of current medical treatment of bronchopulmonary suppurations].
    Unteanu G; Neagu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(3):227-34. PubMed ID: 6296978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical relevance of intracellular and extracellular concentrations of macrolides.
    Carbon C
    Infection; 1995; 23 Suppl 1():S10-4. PubMed ID: 7782109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.